An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients

OBJECTIVES: The present study was performed with the aim of analyzing the biological disease-modifying antirheumatic drug (bDMARD)-free (Bio-free) condition of adalimumab (ADA)-treated rheumatoid arthritis (RA) patients in a real-world setting. METHODS: ADA was used in the treatment of 130 (male, n=...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intern Med
Main Authors: Ito, Satoshi, Kobayashi, Daisuke, Hasegawa, Eriko, Takai, Chinatsu, Nemoto, Tetsuya, Lee, Hyunho, Abe, Asami, Otani, Hiroshi, Ishikawa, Hajime, Murasawa, Akira, Narita, Ichiei, Nakazono, Kiyoshi
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society of Internal Medicine 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6421140/
https://ncbi.nlm.nih.gov/pubmed/30210123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.1332-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados